• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测脾肿大和血小板减少症患者患戈谢病的概率。

Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia.

作者信息

Motta Irene, Consonni Dario, Stroppiano Marina, Benedetto Christian, Cassinerio Elena, Tappino Barbara, Ranalli Paola, Borin Lorenza, Facchini Luca, Patriarca Andrea, Barcellini Wilma, Lanza Federica, Filocamo Mirella, Cappellini Maria Domenica

机构信息

General Medicine Unit, Rare Diseases Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza, 35, 20122, Milan, Italy.

Department of Clinical Sciences and Community Health, Università Degli Studi Di Milano, Milan, Italy.

出版信息

Sci Rep. 2021 Jan 28;11(1):2594. doi: 10.1038/s41598-021-82296-z.

DOI:10.1038/s41598-021-82296-z
PMID:33510429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7843616/
Abstract

Hematologists are frequently involved in the diagnostic pathway of Gaucher disease type 1 (GD1) patients since they present several hematological signs. However, GD1 is mainly underdiagnosed because of a lack of awareness. In this multicenter study, we combine the use of a diagnostic algorithm with a simple test (β-glucosidase activity on Dried Blood Spot) in order to facilitate the diagnosis in a population presenting to the hematologist with splenomegaly and/or thrombocytopenia associated with other hematological signs. In this high-risk population, the prevalence of GD1 is 3.3%. We propose an equation that predicts the probability of having GD1 according to three parameters that are routinely evaluated: platelet count, ferritin, and transferrin saturation.

摘要

血液科医生经常参与1型戈谢病(GD1)患者的诊断过程,因为这些患者会出现多种血液学体征。然而,由于认识不足,GD1主要存在诊断不足的情况。在这项多中心研究中,我们将诊断算法与一项简单检测(干血斑上的β-葡萄糖苷酶活性)相结合,以便在因脾肿大和/或血小板减少症以及其他血液学体征而前来血液科就诊的人群中促进诊断。在这个高危人群中,GD1的患病率为3.3%。我们提出了一个根据三个常规评估参数(血小板计数、铁蛋白和转铁蛋白饱和度)预测患GD1概率的方程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3559/7843616/139264851952/41598_2021_82296_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3559/7843616/3d9b68f25971/41598_2021_82296_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3559/7843616/139264851952/41598_2021_82296_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3559/7843616/3d9b68f25971/41598_2021_82296_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3559/7843616/139264851952/41598_2021_82296_Fig2_HTML.jpg

相似文献

1
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia.预测脾肿大和血小板减少症患者患戈谢病的概率。
Sci Rep. 2021 Jan 28;11(1):2594. doi: 10.1038/s41598-021-82296-z.
2
A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and/or Thrombocytopenia.一项针对脾肿大和/或血小板减少症患者戈谢病早期诊断的多中心观察性研究。
Eur J Haematol. 2016 Apr;96(4):352-9. doi: 10.1111/ejh.12596. Epub 2015 Jun 11.
3
High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.中国伴脾大及/或血小板减少的患者行戈谢病高危筛查:发现 55 例。
Clin Chim Acta. 2020 Jul;506:22-27. doi: 10.1016/j.cca.2020.03.016. Epub 2020 Mar 9.
4
Assessing the diagnostic utility of the Gaucher Earlier Diagnosis Consensus (GED-C) scoring system using real-world data.使用真实世界数据评估 Gaucher 早期诊断共识 (GED-C) 评分系统的诊断效用。
Orphanet J Rare Dis. 2024 Feb 16;19(1):71. doi: 10.1186/s13023-024-03042-y.
5
Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1.不同骨髓检查方法在成人散发性1型戈谢病诊断中的临床应用
Pol Arch Med Wewn. 2014;124(11):587-92. doi: 10.20452/pamw.2493. Epub 2014 Sep 3.
6
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia.GAU-PED 研究:用于诊断脾肿大伴血细胞减少的儿童戈谢病的早期检测。
Orphanet J Rare Dis. 2023 Jun 16;18(1):151. doi: 10.1186/s13023-023-02760-z.
7
Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India.成年I型戈谢病患者的生化和分子特征以及Leu444Pro(印度常见的戈谢病突变)的携带者频率分析
BMC Med Genet. 2018 Oct 1;19(1):178. doi: 10.1186/s12881-018-0687-5.
8
Gaucher Disease for Hematologists.戈谢病的血液学特点
Turk J Haematol. 2022 Jun 1;39(2):136-139. doi: 10.4274/tjh.galenos.2021.2021.0683. Epub 2022 Apr 20.
9
Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.Ⅰ型戈谢病患者在经过伊米苷酶治疗 4-5 年后仍存在持续性血小板减少症的特征。
Br J Haematol. 2012 Aug;158(4):528-38. doi: 10.1111/j.1365-2141.2012.09175.x. Epub 2012 May 29.
10
Partial splenic embolization in a child with Gaucher disease, massive splenomegaly and severe thrombocytopenia.戈谢病患儿的部分脾栓塞术,伴有巨大脾肿大和严重血小板减少症。
Pediatr Radiol. 2009 Sep;39(9):1006-9. doi: 10.1007/s00247-009-1303-9. Epub 2009 May 27.

引用本文的文献

1
SplenoMegaly study (SMS): exploring the etiologies for "unexplained" splenomegalies in the real world.脾肿大研究(SMS):探索现实世界中“不明原因”脾肿大的病因。
Orphanet J Rare Dis. 2025 Jun 6;20(1):285. doi: 10.1186/s13023-025-03768-3.
2
Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy.对患有隐源性脾肿大和脾切除术的西班牙成年及儿科患者的研究。
Diseases. 2025 Mar 30;13(4):102. doi: 10.3390/diseases13040102.
3
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease.

本文引用的文献

1
High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.中国伴脾大及/或血小板减少的患者行戈谢病高危筛查:发现 55 例。
Clin Chim Acta. 2020 Jul;506:22-27. doi: 10.1016/j.cca.2020.03.016. Epub 2020 Mar 9.
2
Hyperferritinemia and diagnosis of type 1 Gaucher disease.高铁蛋白血症与1型戈谢病的诊断
Am J Hematol. 2020 May;95(5):570-576. doi: 10.1002/ajh.25752. Epub 2020 Feb 22.
3
Gaucher disease screening at a general adult hematology tertiary care centre: A prospective study.
酶替代疗法可改善戈谢病中的红细胞生成和铁代谢失调。
Ann Hematol. 2024 Dec;103(12):5113-5121. doi: 10.1007/s00277-024-05918-2. Epub 2024 Oct 7.
4
The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases.儿童期淋巴细胞增殖的病因学全景:关于一种诊断方法的建议,该方法从感染探索至先天性免疫缺陷和代谢性疾病。
Ther Clin Risk Manag. 2024 May 16;20:261-274. doi: 10.2147/TCRM.S462996. eCollection 2024.
5
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis.戈谢病还是酸性鞘磷脂酶缺乏症?鉴别诊断的重要性。
J Clin Med. 2024 Mar 5;13(5):1487. doi: 10.3390/jcm13051487.
6
Blood cytopenias as manifestations of inherited metabolic diseases: a narrative review.遗传性代谢疾病的血液细胞减少症表现:叙述性综述。
Orphanet J Rare Dis. 2024 Feb 14;19(1):65. doi: 10.1186/s13023-024-03074-4.
7
Development of a rare disease algorithm to identify persons at risk of Gaucher disease using electronic health records in the United States.开发一种罕见病算法,以利用美国电子健康记录识别戈谢病高危人群。
Orphanet J Rare Dis. 2023 Sep 9;18(1):280. doi: 10.1186/s13023-023-02868-2.
8
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia.GAU-PED 研究:用于诊断脾肿大伴血细胞减少的儿童戈谢病的早期检测。
Orphanet J Rare Dis. 2023 Jun 16;18(1):151. doi: 10.1186/s13023-023-02760-z.
9
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.靶向 COVID-19 和戈谢病中的补体-鞘脂系统:一种新治疗策略的证据。
Int J Mol Sci. 2022 Nov 18;23(22):14340. doi: 10.3390/ijms232214340.
10
Targeted Screening for Gaucher Disease in High Suspicion Patients and Clinical Profile of Screen Positives in a Large Pediatric Multispecialty Hospital.大型儿科综合专科医院对高疑似戈谢病患者的靶向筛查及筛查阳性患者的临床特征
Cureus. 2022 Oct 3;14(10):e29868. doi: 10.7759/cureus.29868. eCollection 2022 Oct.
Int J Lab Hematol. 2019 Jun;41(3):e66-e69. doi: 10.1111/ijlh.12960. Epub 2018 Dec 4.
4
The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants.纽约飞行员新生儿溶酶体贮积病筛查计划:首批 65000 例婴儿报告。
Genet Med. 2019 Mar;21(3):631-640. doi: 10.1038/s41436-018-0129-y. Epub 2018 Aug 10.
5
A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China.中国山东省应用干血片法对高危戈谢氏病患儿的初步筛查
Orphanet J Rare Dis. 2018 Apr 6;13(1):48. doi: 10.1186/s13023-018-0782-x.
6
Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease.肝铁调素在戈谢病中铁代谢失调中的作用。
Haematologica. 2018 Apr;103(4):587-596. doi: 10.3324/haematol.2017.177816. Epub 2018 Jan 5.
7
Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.意大利东北部通过串联质谱法进行溶酶体贮积症的新生儿筛查。
J Inherit Metab Dis. 2018 Mar;41(2):209-219. doi: 10.1007/s10545-017-0098-3. Epub 2017 Nov 15.
8
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.从 212 名戈谢病患者和 16 名戈谢病专家医生的角度探讨戈谢病的诊断之旅。
Mol Genet Metab. 2017 Nov;122(3):122-129. doi: 10.1016/j.ymgme.2017.08.002. Epub 2017 Aug 4.
9
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience.伊利诺伊州溶酶体贮积症的新生儿筛查:最初15个月的经验
J Pediatr. 2017 Nov;190:130-135. doi: 10.1016/j.jpeds.2017.06.048. Epub 2017 Jul 17.
10
Effect of temperature on lysosomal enzyme activity during preparation and storage of dried blood spots.温度对干血斑制备和储存过程中溶酶体酶活性的影响
J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22220. Epub 2017 Mar 27.